Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Research Funding » Estonia Invests €5M to Genotype 100K People in 2018 as Part of Personalized Medicine Project

Estonia Invests €5M to Genotype 100K People in 2018 as Part of Personalized Medicine Project

Dec 21, 2017
|
Justin Petrone

NEW YORK (GenomeWeb) – The Estonian government announced this week that it has allocated €5 million ($5.9 million) to support the genotyping of 100,000 people in the Northern European country next year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Through a Picture

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

Lancet, NEJM Papers Now Retracted

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Research Theft Bill to Be Proposed

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

Science Studies Examine Ancient Caribbean Islander Genomes, Barcoding to Track Food Contamination, More

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.

What's Popular?

In Genetic Research

  1. Ancient DNA Points to Multiple Early Migration Waves Into Caribbean

  2. Genetic Analysis of Dead Sea Scrolls Provides Insights Into Origins, Historical Context

  3. SARS-CoV-2 Result of Bat, Pangolin Virus Recombination, Purifying Selection, Study Suggests

  4. Oncotype DX May Be Helpful in Guiding Neoadjuvant Breast Cancer Treatment Decisions

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.